Fortress Biotech, Inc. FBIO
Set alert
1.93 USD +0.01 +0.52%
At close · Nov 2
1.93 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
1.86 Day range 1.94
1.83 52-week range 4.53
- YTD
- -47.27%
- 1 year
- -24.61%
- Open
- 1.89
- Prev close
- 1.92
- Mkt cap
- 64.37M
- Vol
- 198.15K
- Avg vol
- 370.83K
- EPS
- 2.76
- P/E
- 0.70
- Div yield
- 0.00%
More statistics
- Low
- 1.86
- High
- 1.94
- Forward P/E
- -0.99
- Beta
- 1.75
- Short ratio
- 4.57
- Inst. own
- 15.78%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.83
- 200-d avg
- 1.84
- 1y target
- 14.33
5D chart
Signals (43)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:50 PM | 16 hours ago |
| MACD: Sell Signal | Nov 2, 3:50 PM | 16 hours ago |
| MACD: Buy Signal | Nov 2, 3:35 PM | 16 hours ago |
| MACD: Sell Signal | Nov 2, 3:25 PM | 17 hours ago |
| MACD: Buy Signal | Nov 2, 3:20 PM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 3:15 PM | 17 hours ago |
| MACD: Buy Signal | Nov 2, 3:10 PM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 2:10 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 11:35 AM | 20 hours ago |
| MACD: Buy Signal | Nov 2, 11:35 AM | 20 hours ago |
| MACD: Sell Signal | Nov 2, 10:35 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 10:10 AM | 22 hours ago |
| SMA: Bearish | Nov 2, 10:10 AM | 22 hours ago |
| MACD: Buy Signal | Nov 2, 9:55 AM | 22 hours ago |
| SMA: Bullish | Nov 2, 9:50 AM | 22 hours ago |
| MACD: Sell Signal | Nov 2, 9:40 AM | 22 hours ago |
| SMA: Bearish | Nov 2, 9:35 AM | 22 hours ago |
| SMA: Bearish | Nov 2, 9:35 AM | 22 hours ago |
| SMA: Bullish | Oct 30, 2:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 1:05 PM | 3 days ago |
Newest 20 of 43.
Analyst view
Consensus: none
Price target (mean) 14.33 +642.7% upside
Now 1.93
- Target (low)
- 4.00
- Target (mean)
- 14.33
- Target (high)
- 24.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.75 | -0.75 – -0.75 | 0.00 | 0.0% | 15.58M | -24.4% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -3.28 | -3.28 – -3.28 | 0.00 | 0.0% | 58.13M | -31.2% | 1 |
| Next year | -0.87 | -0.87 – -0.87 | -3.28 | +73.5% | 136.43M | +134.7% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 18, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 20, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| May 16, 2024 | Roth MKM | Reiterated | Buy | Buy |
| Mar 19, 2024 | Alliance Global Partners | Initiated | — | Buy |
| Nov 29, 2023 | Roth MKM | Maintained | Buy | Buy |